Allium Financial Advisors »

Regeneron Pharmaceuticals shares owned by Allium Financial Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Allium Financial Advisors from 13F filings

Historical chart of Allium Financial Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Allium Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Allium Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $212k 274 771.87
2025-03-31 $256k 404 634.23

More positions owned by Allium Financial Advisors

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Tr Core S&p500 Etf (IVV)
Runway Growth Finance Corp (RWAY)
Costco Wholesale Corporation (COST)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Pimco Dynamic Income SHS (PDI)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Rus Mid Cap Etf (IWR)
Amazon (AMZN)
Dimensional Etf Trust Us Equity Market (DFUS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for Allium Financial Advisors

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals